Drug | Tablet
Rasagiline 0.5 mg (as rasagiline mesylate) tablet
Treatment of Parkinson’s disease, as monotherapy in early Parkinson’s disease or as add-on to levodopa in patients with motor fluctuations (wearing-off).
Rasagiline is a selective, irreversible monoamine oxidase-B (MAO-B) inhibitor. It increases dopamine levels in the brain by reducing dopamine breakdown, improving motor symptoms of Parkinson’s disease.
Oral tablet; take exactly as prescribed, usually once daily at the same time each day. Can be taken with or without food. Do not stop or change dose without medical advice.
Common side effects of Rasalect 0.5 Tablet may include:
Prescription medicine. Risk of hypertensive crisis with tyramine-rich foods or interacting drugs; follow diet/medicine advice. May cause dizziness or orthostatic hypotension—use caution while driving/standing up. Watch for serotonin syndrome when combined with serotonergic medicines. Use caution in hepatic impairment; avoid in severe liver disease. Report hallucinations, impulse-control disorders, or worsening dyskinesia (especially with levodopa).
